Abstract

Background:In the last couple of years, there has been increased awareness regarding possible effects of chronic inflammatory joint diseases (IJDs) on male fertility. The iFAME-fertility study [1] from The Netherlands...

Full Text

Published Version

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
OP0102 THE SYNOVIUM IN CHRONIC INFLAMMATORY JOINT DISEASES: COMPARISON OF CLINICAL, HISTOLOGICAL AND scRNA-SEQ Data BETWEEN RA, PsA, SpA AND UA
R Micheroli ... S G Edalat
Annals of the Rheumatic Diseases | VOL. 81
R Micheroli, et. al.R Micheroli ... S G Edalat
23 May 2022
AB0029 NO PREDICTIVE EFFECT OF OBESITY ON CLINICAL RESPONSE IN PATIENTS WITH RA AND SpA AFTER 3 YEARS OF BIOLOGIC DRUGS: A MULTICENTER STUDY
N El Ouardi ... A Bezza
Annals of the Rheumatic Diseases | VOL. 83
N El Ouardi, et. al.N El Ouardi ... A Bezza
01 Jun 2024
Male patients with inflammatory joint diseases are less likely than controls to be childless: results from a Norwegian population-based cohort study of 10 865 patients
Gudrun David Sigmo ... Bjorg-Tilde Svanes Fevang
Annals of the Rheumatic Diseases | VOL. 83
Gudrun David Sigmo, et. al.Gudrun David Sigmo ... Bjorg-Tilde Svanes Fevang
23 Jan 2024
FRI0125 Exploring The Inadequate Cardiovascular Disease Prevention in Inflammatory Joint Diseases: Results from The NOCAR Project
E Ikdahl ... F Krøll
Annals of the Rheumatic Diseases | VOL. 75
E Ikdahl, et. al.E Ikdahl ... F Krøll
01 Jun 2016
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults
Elizabeth M Winter ... Anne T Leerling
Annals of the Rheumatic Diseases | VOL. -
Elizabeth M Winter, et. al.Elizabeth M Winter ... Anne T Leerling
28 Nov 2024
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
Jinjing Liu ... Xiaofeng Zeng
Annals of the Rheumatic Diseases | VOL. -
Jinjing Liu, et. al.Jinjing Liu ... Xiaofeng Zeng
27 Nov 2024
CD-19 CAR-T cells for polyrefractory rheumatoid arthritis
Merav Lidar ... Abraham Avigdor
Annals of the Rheumatic Diseases | VOL. -
Merav Lidar, et. al.Merav Lidar ... Abraham Avigdor
27 Nov 2024
Correction: Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment
-
Annals of the Rheumatic Diseases | VOL. -
--
27 Nov 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.